Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INTUNIV
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
- Combining Varenicline and Guanfacine for Smoking Cessation
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
- Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
- Guanfacine Extended Release and Mindfulness Skills Therapy
- The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
- An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
- Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).
- ADHD Medication and Predictors of Treatment Outcome
- Guanfacine Clinical Trial for Smoking Cessation
- Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
- Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD
- PK/PD Comparison of Guanfacine ER and IR
- Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
- Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
- Guanfacine in Children With Tic Disorders
- Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe
- SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
- Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence
- Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
- Inuniv and Working Memory
- Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine
- Interventions for Children With Attention and Reading Disorders
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
- Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
- Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
- A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers
- Efficacy and Safety of SPD503 in Combination With Psychostimulants
Clinical trials list
click for details